Andrea Grace Bocobo

986 total citations
16 papers, 633 citations indexed

About

Andrea Grace Bocobo is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Andrea Grace Bocobo has authored 16 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Surgery and 6 papers in Cancer Research. Recurrent topics in Andrea Grace Bocobo's work include Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Cancer Genomics and Diagnostics (5 papers). Andrea Grace Bocobo is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Cancer Genomics and Diagnostics (5 papers). Andrea Grace Bocobo collaborates with scholars based in United States, Israel and Canada. Andrea Grace Bocobo's co-authors include Rachna T. Shroff, Apurva Jain, Daniel H. Ahn, Tanios Bekaii‐Saab, Milind Javle, Ahmed O. Kaseb, Funda Meric‐Bernstam, Robin Kate Kelley, Ying Wang and Sunil Krishnan and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Oncologist.

In The Last Decade

Andrea Grace Bocobo

15 papers receiving 623 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Andrea Grace Bocobo 506 389 171 170 136 16 633
U. Graeven 169 0.3× 461 1.2× 216 1.3× 198 1.2× 167 1.2× 18 661
K. A. McGlynn 661 1.3× 293 0.8× 354 2.1× 131 0.8× 42 0.3× 6 722
Janne V. Rand 300 0.6× 200 0.5× 98 0.6× 126 0.7× 70 0.5× 6 409
Motonori Sairenji 457 0.9× 314 0.8× 812 4.7× 123 0.7× 36 0.3× 68 1.1k
A. Hay 302 0.6× 274 0.7× 81 0.5× 99 0.6× 61 0.4× 9 693
Jean‐Marie Vandenbulcke 172 0.3× 310 0.8× 216 1.3× 138 0.8× 88 0.6× 9 502
Mamoru Kodani 546 1.1× 571 1.5× 400 2.3× 75 0.4× 27 0.2× 6 820
Ju‐Hee Bang 158 0.3× 261 0.7× 83 0.5× 79 0.5× 43 0.3× 39 385
Ruwaida Begum 205 0.4× 405 1.0× 128 0.7× 67 0.4× 146 1.1× 45 557
Brooke Kania 193 0.4× 324 0.8× 154 0.9× 130 0.8× 53 0.4× 36 475

Countries citing papers authored by Andrea Grace Bocobo

Since Specialization
Citations

This map shows the geographic impact of Andrea Grace Bocobo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Grace Bocobo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Grace Bocobo more than expected).

Fields of papers citing papers by Andrea Grace Bocobo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Grace Bocobo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Grace Bocobo. The network helps show where Andrea Grace Bocobo may publish in the future.

Co-authorship network of co-authors of Andrea Grace Bocobo

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Grace Bocobo. A scholar is included among the top collaborators of Andrea Grace Bocobo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Grace Bocobo. Andrea Grace Bocobo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Li, Michael, Lindsay M. Hannan, Lipika Goyal, et al.. (2024). Changes in alpha-fetoprotein across the systemic therapy continuum in advanced hepatocellular carcinoma—a real-world, multicenter study. Therapeutic Advances in Medical Oncology. 16. 12741821–12741821. 1 indexed citations
2.
Bocobo, Andrea Grace, Spencer C. Behr, Julia Carnevale, et al.. (2022). Phase II study of pembrolizumab plus capecitabine and bevacizumab in microsatellite stable (MSS) metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 40(16_suppl). 3565–3565. 5 indexed citations
3.
Kelley, Robin Kate, Nancy M. Joseph, Halla Nimeiri, et al.. (2021). Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling. Liver Cancer. 10(6). 561–571. 16 indexed citations
4.
Bocobo, Andrea Grace, Spencer C. Behr, Julia Carnevale, et al.. (2021). Phase II study of pembrolizumab plus capecitabine and bevacizumab in microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Interim analysis.. Journal of Clinical Oncology. 39(3_suppl). 77–77. 13 indexed citations
5.
Blarigan, Erin L. Van, Stacey A. Kenfield, June M. Chan, et al.. (2020). Feasibility and Acceptability of a Web-Based Dietary Intervention with Text Messages for Colorectal Cancer: A Randomized Pilot Trial. Cancer Epidemiology Biomarkers & Prevention. 29(4). 752–760. 23 indexed citations
6.
Bocobo, Andrea Grace, Paige M. Bracci, Anna L. Parks, et al.. (2019). Changes in alpha-fetoprotein (AFP) and systemic therapy outcomes in advanced hepatocellular carcinoma (HCC): A multicenter retrospective analysis.. Journal of Clinical Oncology. 37(4_suppl). 346–346. 2 indexed citations
7.
Lowery, Maeve A., Laura W. Goff, Bridget P. Keenan, et al.. (2019). Second‐line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes. Cancer. 125(24). 4426–4434. 51 indexed citations
8.
Jain, Apurva, Mitesh J. Borad, Robin Kate Kelley, et al.. (2018). Cholangiocarcinoma With FGFR Genetic Aberrations: A Unique Clinical Phenotype. JCO Precision Oncology. 2(2). 1–12. 123 indexed citations
9.
Kambhampati, Swetha, et al.. (2018). Nivolumab in advanced hepatocellular carcinoma (HCC) and Child Pugh B (CPB) cirrhosis: Safety and clinical outcomes in a retrospective case series.. Journal of Clinical Oncology. 36(4_suppl). 496–496. 3 indexed citations
10.
11.
Golan, Talia, Maria Raitses‐Gurevich, Robin Kate Kelley, et al.. (2017). Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study. The Oncologist. 22(7). 804–810. 90 indexed citations
12.
Jain, Apurva, Rachna T. Shroff, Robin Kate Kelley, et al.. (2016). FGFR pathway genetic aberrations in cholangiocarcinoma: Demographics and experience with targeted therapy.. Journal of Clinical Oncology. 34(15_suppl). 109–109. 7 indexed citations
13.
Kelley, Robin Kate, John D. Gordan, Kimberley Evason, et al.. (2016). Next-generation sequencing (NGS) in an advanced hepatocellular carcinoma (HCC) cohort: Analyses of TP53 and CTNNB1.. Journal of Clinical Oncology. 34(4_suppl). 286–286. 1 indexed citations
14.
Lowery, Maeve A., Laura W. Goff, Emmet Jordan, et al.. (2016). Second-line chemotherapy (CTx) outcomes in advanced biliary cancers (ABC): A retrospective multicenter analysis.. Journal of Clinical Oncology. 34(4_suppl). 437–437. 4 indexed citations
15.
Javle, Milind, Tanios Bekaii‐Saab, Apurva Jain, et al.. (2016). Biliary cancer: Utility of next‐generation sequencing for clinical management. Cancer. 122(24). 3838–3847. 289 indexed citations
16.
Goff, Laura W., Maeve A. Lowery, Emmet Jordan, et al.. (2016). Second-line chemotherapy (CTx) outcomes in advanced biliary cancers (ABC): A retrospective multicenter analysis.. Journal of Clinical Oncology. 34(15_suppl). e15636–e15636. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by U. Graeven Breakdown of academic impact, for papers by K. A. McGlynn Breakdown of academic impact, for papers by Janne V. Rand Breakdown of academic impact, for papers by Motonori Sairenji Breakdown of academic impact, for papers by A. Hay Breakdown of academic impact, for papers by Jean‐Marie Vandenbulcke Breakdown of academic impact, for papers by Mamoru Kodani Breakdown of academic impact, for papers by Ju‐Hee Bang Breakdown of academic impact, for papers by Ruwaida Begum Breakdown of academic impact, for papers by Brooke Kania
Rankless by CCL
2026